louisiana semaglutide constipation law firm What Are the Claims in the Ozempic and Mounjaro Lawsuit? Weight Loss GLP-1s with Compounded glp-1 intestinal paralysis law office

Functions of GLP-1 RA Helps suppress appetite

CNC Accepts Medicare Bridge Wegovy, Zepbound, and Foundayo are covered at $50/month for eligible Medicare patients under the 2026 GLP-1 Bridge program through December 31, 2027

Tirzepatide's dual-action approach Tirzepatide (found in Mounjaro and Zepbound) works differently by activating not one, but two hormone receptors: GLP-1 receptors (the same ones that semaglutide targets) GIP (glucose-dependent insulinotropic polypeptide) receptors This dual-action approach creates complementary effects on hunger, metabolism, and blood sugar regulation and yielding more impactful results than GLP-1 alone

According to the lawsuit, the plaintiff used Wegovy as prescribed before experiencing sudden vision loss

Some patients find the injectable peak-and-recovery cycle more manageable